611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
How Folks Are Coping With Post-COVID Loss of Smell, TasteRoutine Ventilation of Surgical Patients Won't Raise COVID Transmission RiskImmunocompromised May Need Fourth COVID Shot: CDCLiver Transplants Soar as Some Americans Drink Their Way Through the PandemicFDA Advisors Approve Emergency Use of Pfizer COVID Vaccine in Kids 5 to 11COVID Vaccination Can Be Safe Even in People With Severe AllergiesTargeted High-Dose Radiation Helps Fight Advanced Lung CancerTrader Joe's Salami Snacks Tied to 20 Salmonella Cases in 8 StatesWhite House Takes More Steps to Boost Supply of Rapid at-Home COVID TestsBiden Administration Announces Details of Vaccination Requirements for Foreign TravelersAHA News: Never Heard of Sepsis? It's Common, Dangerous and a Threat to Your HeartModerna Says Its COVID Vaccine Works Well in Children Aged 6 to 11COVID Vaccination Does Not Raise Odds of Miscarriage: StudyVaccinated People Less Likely to Die of Any Cause in Months After Shots: CDCRecovering COVID Patients Often Face Long-Term 'Brain Fog'COVID Pandemic May Have Driven a Flu Strain Into ExtinctionThe No. 1 Cause of Halloween Injuries: Carving the PumpkinPfizer Vaccine Prevents 91% of Symptomatic COVID in Young Children: FDAPfizer Says Lower Dose of Its COVID Vaccine Protects Younger ChildrenDeadly Liver Disease Tied to Obesity Is on the RiseCDC Signs Off on Moderna, J&J Boosters, Backs Mix n' Match ShotsMoving Monoclonal Antibody Treatments for COVID From Hospital to HomeConfusion, Seizures: People Hospitalized After Taking Veterinary Drug for COVIDMandates, Not Recommendations, Work Best to Get Folks Vaccinated: StudyPfizer Vaccine Booster Restores Nearly Full Protection, Company SaysTen Years On, Gene Therapy Still Beating Most Cases of 'Bubble Boy' Immune DiseaseSex of Fetus May Matter When COVID Strikes in PregnancyVaccines Cut Odds for Death From COVID Delta Variant by 90%U.S. Has Shared 200 Million Shots With Other CountriesSalmonella Outbreak in 37 States Linked to Imported OnionsFDA Approves Moderna, J&J Booster Shots, Backs Mix n' Match VaccinesWhite House Announces COVID Vaccination Plan for Young KidsEven With Mild COVID, Obesity May Mean Worse SymptomsNew Device Might Spot 'Lazy Eye' in Kids EarlierA High-Tech Pointer to Pollutants That Trigger Asthma in KidsFlu Cases Already Up 23% This Season: WalgreensDoctors Report That Kidney Grown in Pig Worked in a HumanHeartburn Meds Might Be Good for Your GumsOne Big Factor for Survival After Spinal Cord Injury: ResilienceDying Young From Heart Disease: Where You Live in the U.S. MattersFDA Expected to Allow Mix n' Match COVID VaccinesPowell's COVID Death Despite Vaccination Shows Danger to Those With Weakened Immune SystemsAHA News: Your Next Doctor's Prescription Might Be to Spend Time in NatureOut-of-Pocket Medical Bills for COVID-19 May Average $3,800 in 2021: StudyLegionnaires' Disease Outbreak Hits Long Island, N.Y.State Lotteries Didn't Help Boost Vaccination RatesFDA Panel Recommends Approval of Johnson & Johnson Booster ShotHeart Defibs in Schools Are Saving Staff Lives: StudyHorseback Riding Carries Big Risk for Serious Injury: StudyTwo-Thirds of Parents of Kids Ages 5-11 Plan to Get Them Vaccinated Against COVID: Poll
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Antibodies to Early Strains of COVID May Not Fight New Variants: Study

HealthDay News
by Steven Reinberg
Updated: Sep 22nd 2021

new article illustration

WEDNESDAY, Sept. 22, 2021 (HealthDay News) -- Antibodies from current COVID-19 vaccines don't bind well to the new variants of the virus, a study finds.

Researchers collected data from previously published papers about the sequence of antibodies produced by the vaccines. They focused on antibodies against the spike protein, a part of the virus that binds to receptors on human cells to infect them. It's the target of most vaccines.

"Antibody response is quite relevant to everything from understanding natural infection and how we recover from infection to vaccine design," lead researcher Nicholas Wu said in a news release from University of Illinois Urbana-Champaign. He is a professor of biochemistry.

The body can make an estimated 1 trillion different antibodies, so when people are making similar antibodies to a particular virus, it means vaccines can be designed to elicit it. It also means it is likely going to improve responsiveness to it, Wu explained.

This study found that many antibodies converged into two groups, indicating an immune response to the virus.

"We really focused on characterizing the antibodies created in those infected with the original strain of the virus," said first author Timothy Tan, a graduate student.

He noted that variants hadn't been much of a problem before the study began. But, Tan added, once they emerged, researchers wanted to see whether common antibodies were able to bind to newer variants.

"Even though this antibody response is very common with the original strain, it doesn't really interact with variants," Wu said. "That, of course, raises the concern of the virus evolving to escape the body's main antibody response. Some antibodies should still be effective -- the body makes antibodies to many parts of the virus, not only the spike protein -- but the particular groups of antibodies that we saw in this study will not be as effective."

Researchers said they would like to do similar studies of antibody responses to Delta and other variants, to see if they also produce a response and how it differs from the original strain.

The findings were published recently in the journal Nature Communications.

More information

The U.S. Centers for Disease Control and Prevention has more information about COVID-19 vaccines.


SOURCE: University of Illinois Urbana-Champaign, news release, Sept. 17, 2021